And we found that a high expression of LOX-1 was associated with a poor prognosis in GC patients and the prognostic accuracy of the tumor node metastasis (TNM) stage was improved as incorporation with LOX-1 expression. The gene discussed is OLR1; the disease is gastric cancer.